Guest guest Posted October 26, 2008 Report Share Posted October 26, 2008 Analysis of data from several phase I and II clinical trials of a new cancer vaccine has shown it is capable of eliciting an immune response in most patients with bowel, kidney and prostate cancer, and that it may provide clinical benefit.Click on below link for the full story:<http://www.sciencedaily.com/releases/2008/10/081023195220.htm> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.